ZymoGenetics, Inc.
1201 Eastlake Avenue East
Seattle,
WA 98102-3702
United States - Map
Phone: 206-442-6600
Fax: 206-442-6608
Web Site: http://www.zymogenetics.com
| ZymoGenetics, Inc., a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases primarily hemostasis, inflammatory and autoimmune diseases, cancer, and viral infections. It principally markets RECOTHROM, a recombinant thrombin, which is a topical hemostatic agent used for the control of moderate bleeding during surgical procedures. The company’s product candidates in clinical development include atacicept, which is intended for the treatment of systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, multiple myeloma, non-Hodgkin’s lymphoma, and chronic lymphocytic leukemia; IL-21, which is intended for the treatment of metastatic melanoma, metastatic renal cell carcinoma, non-Hodgkin’s lymphoma, colorectal cancer, and ovarian cancer; PEG-IFN-l for the treatment of hepatitis C virus infection and multiple sclerosis; IL-17RC for the treatment of inflammatory diseases; and IL-31 mAb for the treatment of atopic dermatitis and inflammatory diseases. It also offers out-licensed commercial products comprising Novolin and insulin analogs for diabetes; NovoSeven for the treatment of hemophilia; Regranex for wound healing; GEM 21S for periodontal defects; GlucaGen for hypoglycemia and gastrointestinal motility inhibition; and Cleactor for treatment of myocardial infarction. The company’s out-licensed product candidates include GEM-OS1/GEM-OS2 for the treatment of orthopedic fracture and other bone defects; rFactor XIII for the treatment of congenital factor XIII deficiency, cardiac surgery, and cancer treatment; FGF-18 for the treatment of osteoarthritis; and IL-20 and IL-22 receptor, which are intended for the treatment of psoriasis. It has collaborative agreements with Novo Nordisk A/S; Merck Serono S.A.; Bayer Schering Pharma AG; and Bayer HealthCare LLC. The company was founded in 1981 and is headquartered in Seattle, Washington. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Bruce L. A. Carter Ph.D., 64
Chairman and Chief Exec. Officer |
$
888.00K |
$
1.71M | Dr. Douglas Edward Williams Ph.D., 49
Pres and Chief Scientific Officer |
N/A
| N/A | Mr. James A. Johnson , 52
Chief Financial Officer, Principal Accounting Officer, Exec. VP and Treasurer |
N/A
| N/A | Dr. Nicole Onetto M.D., 55
Chief Medical Officer and Sr. VP |
$
445.00K | N/A | Mr. Michael J. Dwyer , 52
Sr. VP of Sales & Marketing and Member of Exec. Management Committee |
$
356.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-07
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.63% Nasdaq 0.00%
Profile
